Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference
![](https://mms.businesswire.com/media/20240430846888/en/1407047/4/Press_Release_Logo.jpg)
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that Steve Uden, M.D., Chief Executive Officer of Rallybio, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024 at 11:30 a.m.